MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway

BACKGROUND: MYO18B has been identified as a novel tumor suppressor gene in several cancers. However, its specific roles in the progression of hepatocellular carcinoma (HCC) has not been well defined. METHODS: We firstly identified the expression and prognostic values of MYO18B in HCC using TCGA coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhenyu, Zhu, Jinfeng, Huang, Yansong, Li, Weibing, Cheng, Hongqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215340/
https://www.ncbi.nlm.nih.gov/pubmed/30390677
http://dx.doi.org/10.1186/s13000-018-0763-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215340/
https://www.ncbi.nlm.nih.gov/pubmed/30390677
http://dx.doi.org/10.1186/s13000-018-0763-3

Ejemplares similares